attenuated Listeria monocytogenes ANZ-100
Term · Oncology and biomedicine · MLC-T-ONC-011291
A live-attenuated strain of the Gram-positive bacterium Listeria monocytogenes (Lm) with potential immunostimulatory and antineoplastic activities. Upon intravenous administration, attenuated Listeria monocytogenes ANZ-100 may accumulate in and infect liver cells where it may activate a potent innate immune response and an adaptive immune response involving the by recruitment and activation of T lymphocytes. This agent may potentiate the immune response to vaccines against various liver neoplasms.
| Identifier | MLC-T-ONC-011291 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | ANZ100 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011291",
"term": "attenuated Listeria monocytogenes ANZ-100",
"field": "Oncology and biomedicine",
"definition": "A live-attenuated strain of the Gram-positive bacterium Listeria monocytogenes (Lm) with potential immunostimulatory and antineoplastic activities. Upon intravenous administration, attenuated Listeria monocytogenes ANZ-100 may accumulate in and infect liver cells where it may activate a potent innate immune response and an adaptive immune response involving the by recruitment and activation of T lymphocytes. This agent may potentiate the immune response to vaccines against various liver neoplasms.",
"synonyms": [
"ANZ100"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/attenuated-listeria-monocytogenes-anz-100/"
}
Record 2,584 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.